# A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

> **NCT00195793** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 174 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** fenofibrate
- **DRUG:** ezetimibe
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00195793
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2007-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195793, "A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00195793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*